ASGE Esophagology: Tailoring Management from Testing to Treatment (Live and Virtual) | July 2022-Risk Stratification of Screening in Barretts Esophagus

Risk Stratification of Screening in Barretts Esophagus

Video Transcription

Video Summary

The video features Prasad Iyer, a professor at the Mayo Clinic, discussing risk stratification of screening and surveillance in Barrett's esophagus. He covers current recommendations for Barrett's screening, available risk assessment scores for Barrett's and esophageal adenocarcinoma, challenges in implementing these scores, and potential future developments. He also discusses factors associated with progression in Barrett's, clinical risk progression scores, biomarkers for risk stratification, and challenges in implementing these biomarkers. He mentions the use of machine learning to develop a risk assessment score using electronic medical records, as well as the use of biomarkers such as p53 and DNA marker panels. He concludes by stating that risk assessment remains critical for Barrett's screening and that progress is being made in personalizing surveillance, but there are still challenges to overcome in implementing these tools.

Asset Subtitle

Prasad Iyer

Keywords

Barrett's esophagus

risk stratification

screening

surveillance

risk assessment scores

biomarkers